Cancer vulnerabilities unveiled by genomic loss

Deepak Nijhawan, Travis I. Zack, Yin Ren, Matthew R. Strickland, Rebecca Lamothe, Steven E. Schumacher, Aviad Tsherniak, Henrike C. Besche, Joseph Rosenbluh, Shyemaa Shehata, Glenn S. Cowley, Barbara A. Weir, Alfred L. Goldberg, Jill P. Mesirov, David E. Root, Sangeeta N. Bhatia, Rameen Beroukhim, William C. Hahn

Research output: Contribution to journalArticle

112 Citations (Scopus)

Abstract

Due to genome instability, most cancers exhibit loss of regions containing tumor suppressor genes and collateral loss of other genes. To identify cancer-specific vulnerabilities that are the result of copy number losses, we performed integrated analyses of genome-wide copy number and RNAi profiles and identified 56 genes for which gene suppression specifically inhibited the proliferation of cells harboring partial copy number loss of that gene. These CYCLOPS (copy number alterations yielding cancer liabilities owing to partial loss) genes are enriched for spliceosome, proteasome, and ribosome components. One CYCLOPS gene, PSMC2, encodes an essential member of the 19S proteasome. Normal cells express excess PSMC2, which resides in a complex with PSMC1, PSMD2, and PSMD5 and acts as a reservoir protecting cells from PSMC2 suppression. Cells harboring partial PSMC2 copy number loss lack this complex and die after PSMC2 suppression. These observations define a distinct class of cancer-specific liabilities resulting from genome instability.

Original languageEnglish (US)
Pages (from-to)842-854
Number of pages13
JournalCell
Volume150
Issue number4
DOIs
StatePublished - Aug 17 2012

Fingerprint

Genes
Genomic Instability
Proteasome Endopeptidase Complex
Neoplasms
Spliceosomes
Gene Dosage
RNA Interference
Tumor Suppressor Genes
Ribosomes
Cell Proliferation
Genome
Tumors

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Nijhawan, D., Zack, T. I., Ren, Y., Strickland, M. R., Lamothe, R., Schumacher, S. E., ... Hahn, W. C. (2012). Cancer vulnerabilities unveiled by genomic loss. Cell, 150(4), 842-854. https://doi.org/10.1016/j.cell.2012.07.023

Cancer vulnerabilities unveiled by genomic loss. / Nijhawan, Deepak; Zack, Travis I.; Ren, Yin; Strickland, Matthew R.; Lamothe, Rebecca; Schumacher, Steven E.; Tsherniak, Aviad; Besche, Henrike C.; Rosenbluh, Joseph; Shehata, Shyemaa; Cowley, Glenn S.; Weir, Barbara A.; Goldberg, Alfred L.; Mesirov, Jill P.; Root, David E.; Bhatia, Sangeeta N.; Beroukhim, Rameen; Hahn, William C.

In: Cell, Vol. 150, No. 4, 17.08.2012, p. 842-854.

Research output: Contribution to journalArticle

Nijhawan, D, Zack, TI, Ren, Y, Strickland, MR, Lamothe, R, Schumacher, SE, Tsherniak, A, Besche, HC, Rosenbluh, J, Shehata, S, Cowley, GS, Weir, BA, Goldberg, AL, Mesirov, JP, Root, DE, Bhatia, SN, Beroukhim, R & Hahn, WC 2012, 'Cancer vulnerabilities unveiled by genomic loss', Cell, vol. 150, no. 4, pp. 842-854. https://doi.org/10.1016/j.cell.2012.07.023
Nijhawan D, Zack TI, Ren Y, Strickland MR, Lamothe R, Schumacher SE et al. Cancer vulnerabilities unveiled by genomic loss. Cell. 2012 Aug 17;150(4):842-854. https://doi.org/10.1016/j.cell.2012.07.023
Nijhawan, Deepak ; Zack, Travis I. ; Ren, Yin ; Strickland, Matthew R. ; Lamothe, Rebecca ; Schumacher, Steven E. ; Tsherniak, Aviad ; Besche, Henrike C. ; Rosenbluh, Joseph ; Shehata, Shyemaa ; Cowley, Glenn S. ; Weir, Barbara A. ; Goldberg, Alfred L. ; Mesirov, Jill P. ; Root, David E. ; Bhatia, Sangeeta N. ; Beroukhim, Rameen ; Hahn, William C. / Cancer vulnerabilities unveiled by genomic loss. In: Cell. 2012 ; Vol. 150, No. 4. pp. 842-854.
@article{3ead08e12b424268a7d94334265de3fa,
title = "Cancer vulnerabilities unveiled by genomic loss",
abstract = "Due to genome instability, most cancers exhibit loss of regions containing tumor suppressor genes and collateral loss of other genes. To identify cancer-specific vulnerabilities that are the result of copy number losses, we performed integrated analyses of genome-wide copy number and RNAi profiles and identified 56 genes for which gene suppression specifically inhibited the proliferation of cells harboring partial copy number loss of that gene. These CYCLOPS (copy number alterations yielding cancer liabilities owing to partial loss) genes are enriched for spliceosome, proteasome, and ribosome components. One CYCLOPS gene, PSMC2, encodes an essential member of the 19S proteasome. Normal cells express excess PSMC2, which resides in a complex with PSMC1, PSMD2, and PSMD5 and acts as a reservoir protecting cells from PSMC2 suppression. Cells harboring partial PSMC2 copy number loss lack this complex and die after PSMC2 suppression. These observations define a distinct class of cancer-specific liabilities resulting from genome instability.",
author = "Deepak Nijhawan and Zack, {Travis I.} and Yin Ren and Strickland, {Matthew R.} and Rebecca Lamothe and Schumacher, {Steven E.} and Aviad Tsherniak and Besche, {Henrike C.} and Joseph Rosenbluh and Shyemaa Shehata and Cowley, {Glenn S.} and Weir, {Barbara A.} and Goldberg, {Alfred L.} and Mesirov, {Jill P.} and Root, {David E.} and Bhatia, {Sangeeta N.} and Rameen Beroukhim and Hahn, {William C.}",
year = "2012",
month = "8",
day = "17",
doi = "10.1016/j.cell.2012.07.023",
language = "English (US)",
volume = "150",
pages = "842--854",
journal = "Cell",
issn = "0092-8674",
publisher = "Cell Press",
number = "4",

}

TY - JOUR

T1 - Cancer vulnerabilities unveiled by genomic loss

AU - Nijhawan, Deepak

AU - Zack, Travis I.

AU - Ren, Yin

AU - Strickland, Matthew R.

AU - Lamothe, Rebecca

AU - Schumacher, Steven E.

AU - Tsherniak, Aviad

AU - Besche, Henrike C.

AU - Rosenbluh, Joseph

AU - Shehata, Shyemaa

AU - Cowley, Glenn S.

AU - Weir, Barbara A.

AU - Goldberg, Alfred L.

AU - Mesirov, Jill P.

AU - Root, David E.

AU - Bhatia, Sangeeta N.

AU - Beroukhim, Rameen

AU - Hahn, William C.

PY - 2012/8/17

Y1 - 2012/8/17

N2 - Due to genome instability, most cancers exhibit loss of regions containing tumor suppressor genes and collateral loss of other genes. To identify cancer-specific vulnerabilities that are the result of copy number losses, we performed integrated analyses of genome-wide copy number and RNAi profiles and identified 56 genes for which gene suppression specifically inhibited the proliferation of cells harboring partial copy number loss of that gene. These CYCLOPS (copy number alterations yielding cancer liabilities owing to partial loss) genes are enriched for spliceosome, proteasome, and ribosome components. One CYCLOPS gene, PSMC2, encodes an essential member of the 19S proteasome. Normal cells express excess PSMC2, which resides in a complex with PSMC1, PSMD2, and PSMD5 and acts as a reservoir protecting cells from PSMC2 suppression. Cells harboring partial PSMC2 copy number loss lack this complex and die after PSMC2 suppression. These observations define a distinct class of cancer-specific liabilities resulting from genome instability.

AB - Due to genome instability, most cancers exhibit loss of regions containing tumor suppressor genes and collateral loss of other genes. To identify cancer-specific vulnerabilities that are the result of copy number losses, we performed integrated analyses of genome-wide copy number and RNAi profiles and identified 56 genes for which gene suppression specifically inhibited the proliferation of cells harboring partial copy number loss of that gene. These CYCLOPS (copy number alterations yielding cancer liabilities owing to partial loss) genes are enriched for spliceosome, proteasome, and ribosome components. One CYCLOPS gene, PSMC2, encodes an essential member of the 19S proteasome. Normal cells express excess PSMC2, which resides in a complex with PSMC1, PSMD2, and PSMD5 and acts as a reservoir protecting cells from PSMC2 suppression. Cells harboring partial PSMC2 copy number loss lack this complex and die after PSMC2 suppression. These observations define a distinct class of cancer-specific liabilities resulting from genome instability.

UR - http://www.scopus.com/inward/record.url?scp=84865227709&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84865227709&partnerID=8YFLogxK

U2 - 10.1016/j.cell.2012.07.023

DO - 10.1016/j.cell.2012.07.023

M3 - Article

VL - 150

SP - 842

EP - 854

JO - Cell

JF - Cell

SN - 0092-8674

IS - 4

ER -